W STRATEGIES, LLC

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · Biopharmaceutical Company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $80,000.00 income · posted Jul 18, 2025

Bills named in this filing 2

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 946
ORPHAN Cures Act

Lobbying activity 1

Medicare/Medicaid

H.R.1 - One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.